KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mannkind (MNKD) Asset Writedowns and Impairment (2017 - 2025)

Mannkind (MNKD) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 5.47% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.4 million, a 166.67% increase, with the full-year FY2025 number at $10.4 million, up 166.67% from a year prior.
  • Asset Writedowns and Impairment was $2.1 million for Q4 2025 at Mannkind, down from $3.2 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.6 million in Q2 2025 to a low of $300000.0 in Q3 2023.
  • A 5-year average of $1.4 million and a median of $937000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 65.44% in 2023, then skyrocketed 949.19% in 2025.
  • Mannkind's Asset Writedowns and Impairment stood at $1.9 million in 2021, then crashed by 56.15% to $834000.0 in 2022, then rose by 4.8% to $874000.0 in 2023, then surged by 127.8% to $2.0 million in 2024, then grew by 5.47% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for MNKD's Asset Writedowns and Impairment are $2.1 million (Q4 2025), $3.2 million (Q3 2025), and $4.6 million (Q2 2025).